drugset / Trial / NCT03413618

Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis

NCT03413618

RandomizedParallel-groupSingle-blindTreatment

Summary

The randomized clinical study aimed to assess the efficacy and safety of standard anticoagulation with rivaroxaban in combination with diosmin compared to the isolated use of standard rivaroxaban for prolonged therapy of acute femoro-popliteal deep vein thrombosis reflected the speed of deep vein recanalization and incidence of post-thrombotic syndrome.

Timeline

Start
2017-12-20
Primary completion
2019-07-31
Completion
2019-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Diosmin Small molecule 600 mg
Background Rivaroxaban Other / unclassified 20 mg